Results 331 to 340 of about 4,906,436 (344)

Unexpected Off-Targets and Paradoxical Pathway Activation by Kinase Inhibitors

ACS Chemical Biology, 2015
Oliver D Hantschel
exaly  

Advances in the studies of roles of Rho/Rho-kinase in diseases and the development of its inhibitors

European Journal of Medicinal Chemistry, 2013
Shijun Wen, Rongbiao Pi
exaly  

A small molecule–kinase interaction map for clinical kinase inhibitors

Nature Biotechnology, 2005
M. A. Fabian, W. Biggs, D. K. Treiber, Corey E Atteridge, Mihai Dumitru Azimioara, Michael G. Benedetti, T. A. Carter, P. Ciceri, Philip T Edeen, Mark Floyd, Julia Ford, M. Galvin, Jay L. Gerlach, R. Grotzfeld, S. Herrgård, Darren E. Insko, M. Insko, Andiliy G. Lai, J. Lelias, Shamal A. Mehta, Zdravko V. Milanov, A. Velasco, L. Wodicka, H. Patel, P. Zarrinkar, D. Lockhart   +25 more
semanticscholar   +1 more source

Kinase Inhibitors

2012
openaire   +2 more sources

Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer.

Journal of Medicinal Chemistry, 2016
Timothy Heffron
semanticscholar   +1 more source

Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis

ACS Medicinal Chemistry Letters, 2013
Philip A Harris, Deepak Bandyopadhyay, Nino Campobasso   +2 more
exaly  

Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors.

ACS Chemical Biology, 2016
Susan Klaeger, B. Gohlke, Jessica Perrin, Vipul Gupta, S. Heinzlmeir, D. Helm, H. Qiao, G. Bergamini, H. Handa, M. Savitski, M. Bantscheff, G. Médard, R. Preissner, B. Kuster   +13 more
semanticscholar   +1 more source

Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.

Biochemistry, 1984
H. Hidaka, M. Inagaki, S. Kawamoto, Y. Sasaki   +3 more
semanticscholar   +1 more source

Advances in reversible covalent kinase inhibitors

Medicinal Research Reviews
Zheng Zhao
exaly  

Clinical pharmacokinetics of tyrosine kinase inhibitors

Cancer Treatment Reviews, 2009
Nielka P Van Erp, Hans Gelderblom, Henk-Jan Guchelaar   +2 more
exaly